Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:03 PM
Study NCT ID:
NCT01153958
Status:
TERMINATED
Last Update Posted:
2014-02-13
First Post:
2010-06-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Colposeptine for the Treatment of Bacterial Vaginosis
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Study Overview
Official Title:
The Use of Colposeptine in Bacterial Vaginosis. A Randomized, Controlled Study
Status:
TERMINATED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective, randomized, controlled and multi-center trial to assess the use of colposeptine in female subjects with bacterial vaginosis. A total of 480 subjects were planned to be enrolled in various centers in China.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: